MedPath

Correlation of Xanthelasma with atherosclerosis, liver fat and fibrosis

Not Applicable
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2023/07/054847
Lead Sponsor
ational Diabetes Obesity and Cholesterol Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with T2DM

2.Age 25 to 60 years

3.BMI >25 kg/m² to >40 kg/m²

4.Gender- Both (Male & Female)

5.Mild, moderate and severe Xanthelasma (Photograph)

Exclusion Criteria

1.Alcoholic abuse or other causes of liver dysfunction.

2.Severe end organ damage or chronic diseases: renal/hepatic failure, any malignancy, major systemic illness etc.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To correlate xanthelasma & its severity to pulse wave velocity & atherosclerosis as see in carotid doppler.Timepoint: 12 months
Secondary Outcome Measures
NameTimeMethod
To correlate xanthelasma to liver fat & fibrosis.Timepoint: 12 months
© Copyright 2025. All Rights Reserved by MedPath